Bruton's tyrosine kinase homing endonuclease variants, compositions, and methods of use

Abstract

The present disclosure provides improved genome editing compositions and methods for editing a human BTK gene. The disclosure further provides genome edited cells for the prevention, treatment, or amelioration of at least one symptom of X-linked agammaglobulinemia (XLA).

Dependencies are inferred from the claim text.